ResQ Medical

Developer of a cutting-edge device for treating Postpartum Hemorrhage (PPH).

Health Tech & Life Sciences
Active
Seed Yokne'am Illit, Israel Founded 2022
Last updated 2026-07-26
Total raised
$500K
Last: Grant 2022-08
Stage
Seed
Founded
2022
Headcount
4
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

ResQ Medical is an Israeli startup company established in August 2022 with the support of the Israel Innovation Authority (IIA) and Youdim Pharmaceuticals. The company developed ALMA, a safe, effective, cutting-edge device for treating Postpartum Hemorrhage (PPH). Their goal is to become an essential tool in every delivery room and the first choice in the treatment of PPH, aiming to alleviate the risks and potential complications millions of women each year are exposed to during delivery. The ALMA device facilitates uterine contraction to compress and close leaking blood vessels, mimicking natural uterine contraction to control PPH. ResQ Medical has completed a feasibility study with no device-related adverse events. The pivotal study is now enrolling, and commercial preparation is underway.

Funding history · 3 rounds · $500K total

2022-07
Pre-Seed Undisclosed
★ Youdim Pharmaceuticals
2022-07
Grant $500K
2022-07
Seed Undisclosed

Headcount over time

From 6 (2023-05) to 4 (2025-10) · -2 (-33%) · 3 points · source: Finder history + radar grounding
60 2023-05 2025-10

Q&A

What is ResQ Medical's primary focus?
ResQ Medical is developing ALMA, a cutting-edge device designed for treating Postpartum Hemorrhage (PPH).
When was ResQ Medical established?
ResQ Medical was established in August 2022.
How many employees does ResQ Medical currently have?
ResQ Medical has 1-10 employees.
What is the total amount of funding ResQ Medical has raised?
ResQ Medical has raised a total of $800,000.
What was ResQ Medical's most recent funding round?
ResQ Medical's most recent funding was a Grant round in August 2022, which raised $500,000.
Who are the co-founders of ResQ Medical?
The co-founders of ResQ Medical are Dr. Itamar Dach (CEO), Michael Stark, M.D. (Medical leader), and Amnon Weichselbaum (CTO).
What is the current stage of ResQ Medical's product development?
ResQ Medical's product, ALMA, is currently in the R&D stage, with a pivotal study enrolling and commercial preparation underway.
In which sector does ResQ Medical primarily operate?
ResQ Medical operates primarily in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

Team · 3

Dr. Itamar Dach
Founder · CEO & Co-founder
Michael Stark, M.D.
Founder · Medical leader & Co-founder
Amnon Weichselbaum
Founder · CTO & Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

women-healthgynecologyfemtechmedical-devicesbabiespregnancy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteresq-med.com
LinkedInlinkedin.com/company/88426026

Identifiers & details

Legal nameresq medical ltd
Founded2022-8
Employees (exact)4

Radar intelligence

Patents

EPO2

GitHub

Top reposapi-examples, node-bleacon

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516181633
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2020-03-31
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events4 — shares_capital (2), other (1), charge (1)
Registered addressהצמיחה 1 יקנעם עילית

Recent registry events

DateEvent
2026-02-24העברת מניות
2026-01-20שינוי בתקנון
2026-06-17הקצאת מניות
2026-01-14סילוק שעבוד